▁as ▁some ▁women ▁taking ▁dan az ol ▁may ▁experience ▁unw anted ▁hair ▁growth ▁( h irs ut ism ), ▁ac ne , ▁irre vers ible ▁deep ening ▁of ▁the ▁voice , ▁or ▁ad verse ▁blood ▁li pid ▁profiles . ▁In ▁addition , ▁breast ▁at ro phy ▁and ▁decre ased ▁breast ▁size ▁may ▁occur . ▁The ▁drug ▁may ▁also ▁cause ▁hot ▁flash es , ▁elev ation ▁of ▁li ver ▁en zym es , ▁and ▁m ood ▁changes . ▁Some ▁patients ▁who ▁use ▁dan az ol ▁experience ▁weight ▁gain ▁and ▁fluid ▁ret ention . ▁Due ▁to ▁its ▁side ▁effects , ▁dan az ol ▁is ▁s eld om ▁pres cribed ▁continu ously ▁beyond ▁six ▁months . ▁ ▁The ▁use ▁of ▁dan az ol ▁for ▁end omet rios is ▁has ▁been ▁linked ▁to ▁an ▁increased ▁risk ▁of ▁o var ian ▁cancer . ▁Pat ients ▁with ▁end omet rios is ▁have ▁specific ▁risk ▁factors ▁for ▁o var ian ▁cancer , ▁so ▁this ▁may ▁not ▁apply ▁for ▁other ▁uses . ▁Dan az ol , ▁like ▁most ▁other ▁an abol ic ▁ster oid s , ▁has ▁been ▁linked ▁with ▁an ▁increased ▁risk ▁of ▁li ver ▁tum ors . ▁These ▁are ▁generally ▁ben ign . ▁ ▁Ph arm ac ology ▁ ▁Ph arm ac od ynam ics ▁Dan az ol ▁poss esses ▁a ▁complex ▁ph arm ac ology , ▁with ▁multiple ▁mechan isms ▁of ▁action . ▁These ▁include ▁direct ▁binding ▁to ▁and ▁activation ▁of ▁sex ▁h orm one ▁re cept ors , ▁direct ▁in hib ition ▁of ▁en zym es ▁involved